End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.37 EGP | +5.80% | -2.07% | -24.52% |
Mar. 03 | Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 05 | Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index | CI |
Sales 2024 * | 36.64B 782M | Sales 2025 * | 46.76B 998M | Capitalization | 2.39B 50.98M |
---|---|---|---|---|---|
Net income 2024 * | 417M 8.9M | Net income 2025 * | 448M 9.56M | EV / Sales 2024 * | 0.16 x |
Net Debt 2024 * | 3.65B 77.86M | Net Debt 2025 * | 3.44B 73.44M | EV / Sales 2025 * | 0.12 x |
P/E ratio 2024 * |
7.9
x | P/E ratio 2025 * |
5.73
x | Employees | 5,500 |
Yield 2024 * |
2.47% | Yield 2025 * |
2.78% | Free-Float | 61.4% |
1 day | +5.80% | ||
1 week | -2.07% | ||
1 month | -15.96% | ||
3 months | -41.48% | ||
6 months | -2.47% | ||
Current year | -24.52% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 | |
Momen Gomaa
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 2.37 | +5.80% | 13,023,840 |
24-05-15 | 2.24 | 0.00% | 8,294,763 |
24-05-14 | 2.24 | -2.18% | 9,806,960 |
24-05-13 | 2.29 | +2.69% | 11,027,130 |
24-05-12 | 2.23 | -7.85% | 16,522,550 |
End-of-day quote Egyptian Exchange, May 15, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.52% | 50.93M | |
-30.37% | 15.82B | |
-22.51% | 12.65B | |
-22.88% | 6.6B | |
+11.76% | 6.3B | |
-6.01% | 6.11B | |
+64.02% | 4.75B | |
-1.17% | 4.69B | |
-5.58% | 4.02B | |
-7.87% | 3.59B |
- Stock Market
- Equities
- ISPH Stock